<DOC>
	<DOCNO>NCT00106392</DOCNO>
	<brief_summary>The purpose study compare safety effectiveness Prograf prevention erectile dysfunction men radical prostatectomy .</brief_summary>
	<brief_title>A Safety Efficacy Study Prograf Prevention Erectile Dysfunction After Radical Prostatectomy</brief_title>
	<detailed_description>The purpose study compare safety efficacy Prograf versus placebo prevention erectile dysfunction men bilateral nerve-sparing radical prostatectomy .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Male schedule undergo bilateral nerve spar radical prostatectomy prostate cancer . Patient &gt; 65 year age Patient diagnose Type 1 Type 2 diabetes Patient actively smoke daily basis</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Treatment effectiveness</keyword>
	<keyword>Treatment efficacy</keyword>
	<keyword>Investigational , Therapies</keyword>
	<keyword>Immunosuppressant</keyword>
	<keyword>Erectile dysfunction</keyword>
	<keyword>Prostatectomy</keyword>
</DOC>